ADAM19
Disintegrin and metalloproteinase domain-containing protein 19
Also known as: ADA19_HUMAN, MLTNB
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H013
- Gene
- ADAM19
- Ensembl
- ENSG00000135074
- Chromosome
- 5
- Canonical length
- 955 aa
- Protein class
- Plasma proteins, Predicted membrane proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. This member is a type I transmembrane protein and serves as a marker for dendritic cell differentiation. It has been demonstrated to be an active metalloproteinase, which may be involved in normal physiological processes such as cell migration, cell adhesion, cell-cell and cell-matrix interactions, and signal transduction. It is proposed to play a role in pathological processes, such as cancer, inflammatory diseases, renal diseases, and Alzheimer's disease. [provided by RefSeq, May 2013]
Canonical amino-acid sequenceUniProt
955 residues, UniProt reviewed canonical sequence.
>Q9H013|ADAM19
1 MPGGAGAARL CLLAFALQPL RPRAAREPGW TRGSEEGSPK LQHELIIPQW KTSESPVREK
61 HPLKAELRVM AEGRELILDL EKNEQLFAPS YTETHYTSSG NPQTTTRKLE DHCFYHGTVR
121 ETELSSVTLS TCRGIRGLIT VSSNLSYVIE PLPDSKGQHL IYRSEHLKPP PGNCGFEHSK
181 PTTRDWALQF TQQTKKRPRR MKREDLNSMK YVELYLVADY LEFQKNRRDQ DATKHKLIEI
241 ANYVDKFYRS LNIRIALVGL EVWTHGNMCE VSENPYSTLW SFLSWRRKLL AQKYHDNAQL
301 ITGMSFHGTT IGLAPLMAMC SVYQSGGVNM DHSENAIGVA ATMAHEMGHN FGMTHDSADC
361 CSASAADGGC IMAAATGHPF PKVFNGCNRR ELDRYLQSGG GMCLSNMPDT RMLYGGRRCG
421 NGYLEDGEEC DCGEEEECNN PCCNASNCTL RPGAECAHGS CCHQCKLLAP GTLCREQARQ
481 CDLPEFCTGK SPHCPTNFYQ MDGTPCEGGQ AYCYNGMCLT YQEQCQQLWG PGARPAPDLC
541 FEKVNVAGDT FGNCGKDMNG EHRKCNMRDA KCGKIQCQSS EARPLESNAV PIDTTIIMNG
601 RQIQCRGTHV YRGPEEEGDM LDPGLVMTGT KCGYNHICFE GQCRNTSFFE TEGCGKKCNG
661 HGVCNNNQNC HCLPGWAPPF CNTPGHGGSI DSGPMPPESV GPVVAGVLVA ILVLAVLMLM
721 YYCCRQNNKL GQLKPSALPS KLRQQFSCPF RVSQNSGTGH ANPTFKLQTP QGKRKVINTP
781 EILRKPSQPP PRPPPDYLRG GSPPAPLPAH LSRAARNSPG PGSQIERTES SRRPPPSRPI
841 PPAPNCIVSQ DFSRPRPPQK ALPANPVPGR RSLPRPGGAS PLRPPGAGPQ QSRPLAALAP
901 KVSPREALKV KAGTRGLQGG RCRVEKTKQF MLLVVWTELP EQKPRAKHSC FLVPALocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADAM19 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 28 nTPM
- lymph node: 27 nTPM
- heart muscle: 24 nTPM
- appendix: 23 nTPM
- colon: 22 nTPM
- spleen: 22 nTPM
Single-cell type
- cone photoreceptor cells: 375 nCPM
- neutrophils: 370 nCPM
- pdcs: 276 nCPM
- b-cells: 258 nCPM
- rod photoreceptor cells: 253 nCPM
- retinal bipolar cells: 234 nCPM
Immune cell
- eosinophil: 140 nTPM
- basophil: 129 nTPM
- neutrophil: 71 nTPM
- plasmacytoid DC: 67 nTPM
- naive B-cell: 54 nTPM
- memory B-cell: 51 nTPM
Brain region
- cerebellum: 12 nTPM
- medulla oblongata: 12 nTPM
- pons: 11 nTPM
- thalamus: 11 nTPM
- cerebral cortex: 11 nTPM
- midbrain: 10 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.5
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.88
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- amyloid precursor protein catabolic process
- membrane protein ectodomain proteolysis
- placenta development
- positive regulation of cell-cell adhesion mediated by cadherin
- positive regulation of gene expression
- protein processing
Molecular functions
- metal ion binding
- metalloendopeptidase activity
- metalloendopeptidase activity involved in amyloid precursor protein catabolic process
- SH3 domain binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- EGF-like domain
- Peptidase M12B, ADAM/reprolysin
- Disintegrin domain
- Peptidase M12B, propeptide
- ADAM, cysteine-rich domain
- Disintegrin, conserved site
- Metallopeptidase, catalytic domain superfamily
- Reprolysin domain, adamalysin-type
- Disintegrin domain superfamily
- Disintegrin
- Reprolysin (M12B) family zinc metalloprotease
- Reprolysin family propeptide
- ADAM cysteine-rich
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ADAM19 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADAM19 as an antibody target. Whether an autoantibody or antibody against ADAM19 could matter depends on whether native ADAM19 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADAM19 is annotated at the cell surface, where native ADAM19 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ADAM19 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...